SA
BCRX icon

Sanctuary Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History

Sanctuary Advisors’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$530K Sell
55,678
-2,893
-5% -$22.5K ﹤0.01% 1738
2025
Q4 		$457K Buy
58,571
+15,544
+36% +$112K ﹤0.01% 1781
2025
Q3 		$327K Sell
43,027
-1,137
-3% -$9.47K ﹤0.01% 1951
2025
Q2 		$396K Buy
44,164
+649
+1% +$6.04K ﹤0.01% 1755
2025
Q1 		$326K Sell
43,515
-1,272
-3% -$10.3K ﹤0.01% 1741
2024
Q4 		$352K Sell
44,787
-2,602
-5% -$19.8K ﹤0.01% 1898
2024
Q3 		$360K Buy
47,389
+20,818
+78% +$158K ﹤0.01% 1894
2024
Q2 		$111K Buy
+26,571
New +$147K ﹤0.01% 2249

Other funds holding BCRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return